A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India

Background: Mizoram is one of the states in India with the high prevalence of tobacco usage both in terms of smoke form and smokeless form. In spite of high prevalence of smoking, the state has reported less COVID-19 related mortality. The prevalence of tobacco usage among the COVID-19 positive pati...

Full description

Bibliographic Details
Main Authors: Jane R Ralte, Lalrinawmi Hrahsel, Lalnuntluanga Sailo, Ganesh Shanmugasundaram Anusuya, Lalnunmawii Sailo, Lalrem Ruata
Format: Article
Language:English
Published: Manipal College of Medical Sciences, Pokhara 2023-01-01
Series:Asian Journal of Medical Sciences
Subjects:
Online Access:https://www.nepjol.info/index.php/AJMS/article/view/49843
_version_ 1797973796485857280
author Jane R Ralte
Lalrinawmi Hrahsel
Lalnuntluanga Sailo
Ganesh Shanmugasundaram Anusuya
Lalnunmawii Sailo
Lalrem Ruata
author_facet Jane R Ralte
Lalrinawmi Hrahsel
Lalnuntluanga Sailo
Ganesh Shanmugasundaram Anusuya
Lalnunmawii Sailo
Lalrem Ruata
author_sort Jane R Ralte
collection DOAJ
description Background: Mizoram is one of the states in India with the high prevalence of tobacco usage both in terms of smoke form and smokeless form. In spite of high prevalence of smoking, the state has reported less COVID-19 related mortality. The prevalence of tobacco usage among the COVID-19 positive patients and its relation to clinical symptoms and mortality has not been studied in North East part of India. Aims and Objectives: The aim of the study was to study the association of tobacco usage and its relation to clinical symptoms and mortality in COVID-19 patients. Materials and Methods: A total of 100 COVID 19 positive patients admitted in wards of Zoram Medical College, Mizoram between June and August 2020 were selected using convenient sampling. The patients were interviewed over mobile phone after getting informed oral consent. The details regarding socio-demographic variables, tobacco usage, co morbidities, and clinical symptoms were collected from the patients. Comorbidities and smoking were considered as primary outcome variables. The mean values were compared between study groups using independent sample t-test (two groups). Categorical outcomes were compared between study groups using Chi-square test/Fisher’s Exact test (If the overall sample size was <20 or if the expected number in any one of the cells is <5), Fisher’s exact test was used. Results: Out of 100 patients, 54% were males, the mean age was 27.71 years. Recent history of travel was noted in 82% and 12% had history of contact with positive case. Smokers were 42% and 36% were past smokers. The various other forms of tobacco products used were Gutkha (10%), Tuibur (3%), Sahdah (13%), and Kuhva (52%). About 37% were symptomatic. The common symptoms observed were fever (19%), cough (14%), body pain (9%), and sore throat (9%). Only 4% had difficulty in breathing. 19 (45.24%) of the smokers were symptomatic while 18 (31.03%) were symptomatic among nonsmokers (P=0.092). Mortality was 0% among our study population. Conclusion: The present study showed that symptomatic patients were more among smokers when compared with nonsmokers, but the findings were not statistically significant. Hence, further studies needed to be done in this area with a larger sample size.
first_indexed 2024-04-11T04:09:54Z
format Article
id doaj.art-ad7a85dba8d54f94bc131b4e6f8f79e4
institution Directory Open Access Journal
issn 2467-9100
2091-0576
language English
last_indexed 2024-04-11T04:09:54Z
publishDate 2023-01-01
publisher Manipal College of Medical Sciences, Pokhara
record_format Article
series Asian Journal of Medical Sciences
spelling doaj.art-ad7a85dba8d54f94bc131b4e6f8f79e42023-01-01T11:08:34ZengManipal College of Medical Sciences, PokharaAsian Journal of Medical Sciences2467-91002091-05762023-01-011411014https://doi.org/10.3126/ajms.v14i1.49843A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram IndiaJane R Ralte0https://orcid.org/0000-0002-0693-7043Lalrinawmi Hrahsel 1https://orcid.org/0000-0001-6845-5448Lalnuntluanga Sailo 2https://orcid.org/0000-0001-8663-0924Ganesh Shanmugasundaram Anusuya 3https://orcid.org/0000-0002-6853-6616Lalnunmawii Sailo 4https://orcid.org/0000-0001-7991-4224Lalrem Ruata 5https://orcid.org/0000-0002-3822-3774Registrar, Department of Administration, Zoram Medical College, Falkawn, Mizoram, India Statistician Cum Demonstrator, Department of Community Medicine, Zoram Medical College, Falkawn, Mizoram, India Assistant Professor, Department of Respiratory Medicine, Zoram Medical College, Falkawn, Mizoram, India Professor, Department of Community Medicine, Saveetha Medical College and Hospital, Chennai, Tamil Nadu, India Associate Professor, Department of Anaesthesiology and Intensive Care Unit, Zoram Medical College, Falkawn, Mizoram, India Medical Officer, Mizoram Health Services, Mizoram, IndiaBackground: Mizoram is one of the states in India with the high prevalence of tobacco usage both in terms of smoke form and smokeless form. In spite of high prevalence of smoking, the state has reported less COVID-19 related mortality. The prevalence of tobacco usage among the COVID-19 positive patients and its relation to clinical symptoms and mortality has not been studied in North East part of India. Aims and Objectives: The aim of the study was to study the association of tobacco usage and its relation to clinical symptoms and mortality in COVID-19 patients. Materials and Methods: A total of 100 COVID 19 positive patients admitted in wards of Zoram Medical College, Mizoram between June and August 2020 were selected using convenient sampling. The patients were interviewed over mobile phone after getting informed oral consent. The details regarding socio-demographic variables, tobacco usage, co morbidities, and clinical symptoms were collected from the patients. Comorbidities and smoking were considered as primary outcome variables. The mean values were compared between study groups using independent sample t-test (two groups). Categorical outcomes were compared between study groups using Chi-square test/Fisher’s Exact test (If the overall sample size was <20 or if the expected number in any one of the cells is <5), Fisher’s exact test was used. Results: Out of 100 patients, 54% were males, the mean age was 27.71 years. Recent history of travel was noted in 82% and 12% had history of contact with positive case. Smokers were 42% and 36% were past smokers. The various other forms of tobacco products used were Gutkha (10%), Tuibur (3%), Sahdah (13%), and Kuhva (52%). About 37% were symptomatic. The common symptoms observed were fever (19%), cough (14%), body pain (9%), and sore throat (9%). Only 4% had difficulty in breathing. 19 (45.24%) of the smokers were symptomatic while 18 (31.03%) were symptomatic among nonsmokers (P=0.092). Mortality was 0% among our study population. Conclusion: The present study showed that symptomatic patients were more among smokers when compared with nonsmokers, but the findings were not statistically significant. Hence, further studies needed to be done in this area with a larger sample size.https://www.nepjol.info/index.php/AJMS/article/view/49843kuhva; sars-cov-2; north east; prevalence; smoking
spellingShingle Jane R Ralte
Lalrinawmi Hrahsel
Lalnuntluanga Sailo
Ganesh Shanmugasundaram Anusuya
Lalnunmawii Sailo
Lalrem Ruata
A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
Asian Journal of Medical Sciences
kuhva; sars-cov-2; north east; prevalence; smoking
title A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
title_full A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
title_fullStr A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
title_full_unstemmed A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
title_short A cross sectional study on tobacco usage among COVID 19 Positive patients admitted in a tertiary care centre in Mizoram India
title_sort cross sectional study on tobacco usage among covid 19 positive patients admitted in a tertiary care centre in mizoram india
topic kuhva; sars-cov-2; north east; prevalence; smoking
url https://www.nepjol.info/index.php/AJMS/article/view/49843
work_keys_str_mv AT janerralte acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalrinawmihrahsel acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalnuntluangasailo acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT ganeshshanmugasundaramanusuya acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalnunmawiisailo acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalremruata acrosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT janerralte crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalrinawmihrahsel crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalnuntluangasailo crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT ganeshshanmugasundaramanusuya crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalnunmawiisailo crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia
AT lalremruata crosssectionalstudyontobaccousageamongcovid19positivepatientsadmittedinatertiarycarecentreinmizoramindia